Key trends and challenges are shaping the next era of advanced therapies, from FDA momentum to broader patient access.

An increase in hospitalizations related to respiratory disease was found in older adults in the western US. “This information ...

Results presented on Tuesday at the American Association for Cancer Reserch include data on the combined use of tissue and ...

Mike Fazio, director of value-based care at Navista, Cardinal Health, discusses a trending topic at the 2025 Community ...

Nipocalimab (Imaavy; Johnson & Johnson), an FcRn-blocking monoclonal antibody, was approved for patients 12 years and older ...

A panelist discusses how the HIV patient population has aged significantly, with the average age in their clinic now ...

A panelist discusses how viral suppression in HIV patients means achieving undetectable virus levels (below 50 or 20 copies ...

Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering ...

At Asembia’s AXS25 Summit, industry experts explored how pharmacy is evolving to meet rising patient expectations and ...

As the number of cell and gene therapies expands, it's increasingly important for long-term patient data, explained Fran ...

Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported ...

Liver transplantation is the sole curative option for HCC, but new therapies prompt reconsideration of transplant timing and ...